Abstract

Betamethasone Valerate 0.1% Topical Gel

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2007 - Veterinary Compounding

Page(s): 419

Download in electronic PDF format for $75
  • Betamethasone Valerate 0.1% Topical Gel Page 1

Abstract

A formulation for preparing Betamethasone Valerate 0.1% Topical Gel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulations
  • inflammatory skin disorders
  • inflammation
  • betamethasone
  • topical preparations
  • corticosteroids
  • steroids

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2007
Pg. 419
Betamethasone Valerate 0.1% Topical Gel
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 405
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Author(s): Allen Loyd V Jr
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2017
Pg. 312
Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 206-209
Basics of Compounding for Cold Sores or Fever Blisters
Author(s): Allen Loyd V Jr
Jul/Aug 2023
Pg. 319
Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Author(s): Allen Loyd V Jr
Nov/Dec 2014
Pg. 512-515
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Jul/Aug 2023
Pg. 320-321
Cyclosporine Topical Gel Formulation
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
Jul/Aug 2022
Pg. 318
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Author(s): Allen Loyd V Jr
Mar/Apr 2015
Pg. 161-166
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Sep/Oct 2012
Pg. 386-393
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Author(s): Zur Eyal
Nov/Dec 2014
Pg. 504-511
Skin Penetration and Antinociception of Topical Gabapentin Formulations
Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Mar/Apr 2021
Pg. 146-155
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Jul/Aug 2012
Pg. 332
Betamethasone 0.6-mg/5-mL Syrup
Author(s): Allen Loyd V Jr
May/Jun 2011
Pg. 204-213
Treatment Options for Psoriasis
Author(s): Williams LaVonn A, Humphreys Erica